| 1 |
34485865 | Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver. | 2021 Sep 24 |
3 |
| 2 |
30121911 | Modulation of the Inflammatory Status of Macrophages and Their Paracrine Effect on the Sensitivity of Adipocytes to Insulin with Sirtuin and PPARγ Receptor Activators. | 2018 Aug |
1 |
| 3 |
25050627 | Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression. | 2014 Oct |
1 |
| 4 |
25052610 | [Effect of rosiglitazone on the expression of HIF1α and IGF1 mRNA in myeloma]. | 2014 Jul |
2 |
| 5 |
23864113 | Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation. | 2013 Sep |
7 |
| 6 |
22473412 | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study. | 2012 |
1 |
| 7 |
23053988 | Roles of α-linolenic acid on IGF-I secretion and GH/IGF system gene expression in porcine primary hepatocytes. | 2012 Dec |
1 |
| 8 |
20671417 | Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study. | 2011 Feb |
6 |
| 9 |
18475308 | Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. | 2008 Jul-Aug |
1 |
| 10 |
17122083 | Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. | 2007 Feb |
2 |
| 11 |
17309144 | Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. | 2007 Feb |
2 |
| 12 |
16777971 | Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. | 2006 Sep |
1 |
| 13 |
12593999 | Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. | 2003 Feb |
2 |